Public health and medical preparedness for mass casualties from the deliberate release of synthetic opioids
- PMID: 37250077
- PMCID: PMC10213671
- DOI: 10.3389/fpubh.2023.1158479
Public health and medical preparedness for mass casualties from the deliberate release of synthetic opioids
Abstract
The large amounts of opioids and the emergence of increasingly potent illicitly manufactured synthetic opioids circulating in the unregulated drug supply in North America and Europe are fueling not only the ongoing public health crisis of overdose deaths but also raise the risk of another type of disaster: deliberate opioid release with the intention to cause mass harm. Synthetic opioids are highly potent, rapidly acting, can cause fatal ventilatory depression, are widely available, and have the potential to be disseminated for mass exposure, for example, if effectively formulated, via inhalation or ingestion. As in many other chemical incidents, the health consequences of a deliberate release of synthetic opioid would manifest quickly, within minutes. Such an incident is unlikely, but the consequences could be grave. Awareness of the risk of this type of incident and preparedness to respond are required to save lives and reduce illness. Coordinated planning across the entire local community emergency response system is also critical. The ability to rapidly recognize the opioid toxidrome, education on personal protective actions, and training in medical management of individuals experiencing an opioid overdose are key components of preparedness for an opioid mass casualty incident.
Keywords: chemical incident; disaster; emergency preparedness; fentanyl; illicit opioids; naloxone; opioids.
Copyright © 2023 Cibulsky, Wille, Funk, Sokolowski, Gagnon, Lafontaine, Brevett, Jabbour, Cox, Russell, Jett, Thomas and Nelson.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- US Drug Enforcement Administration (DEA) . 2020 National Drug Threat Assessment (2021). 2020 National Drug Threat Assessment (NDTA) (dea.gov). Available online at: https://www.dea.gov/sites/default/files/2021-02/DIR-008-21%202020%20Nati... (accessed January 31, 2022).
-
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . New Psychoactive Substances: 25 Years of Early Warning and Response in Europe: An Update from the EU Early Warning System (2022). New psychoactive substances: 25 years of early warning and response in Europe (europa.eu). Available online at: https://www.emcdda.europa.eu/system/files/publications/14637/20222218_PD... (accessed November 14, 2022).
-
- Public Health Agency of Canada (PHAC) Special Special Advisory Committee on the Epidemic of Opioid Overdoses . Opioid and Stimulant-related Harms in Canada (2022). Available online at: https://health-infobase.canada.ca/substance-related-harms/opioids-stimul... (accessed November 14, 2022).
-
- Heslop DJ, Blain PG. Threat potential of pharmaceutical based agents. Intell Natl Secur. (2020) 35:539–55. 10.1080/02684527.2020.1750158 - DOI
-
- US Government Accountability Office (GAO) Combating Terrorism: Threat Risk Assessments Can Help Prioritize Target Program Investments. GAO/NSIAD-98-74 (1998). Available online at: https://www.gao.gov/products/nsiad-98-74 (accessed January 17, 2023).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
